The nasal vaccine has been approved in the midst of the global coronavirus outbreak as India ramps up its vaccination campaign. Today, the nasal vaccine received approval from the expert group that reviews vaccines.
Nassal Vaccine receives approval from expert group which reviews vaccines
The significant action was taken as Prime Minister Narendra Modi presided over a Covid review meeting to gauge readiness.
Nasal vaccine is thought to be superior than injectable version
For those who avoid injections, the nasal vaccine is a huge comfort. The nasal vaccine is thought to be superior to its injectable version. Mansukh Mandaviya, the Union Health Minister, Amit Shah, the Union Home Minister, Rajesh Bhushan, the Health Secretary, and Dr. VK Paul of the Niti Aayog were all present at the meeting by video call.
Also Read: Covid-19: “Mask up, avoid international travel,” Indian Medical Association issues advisory
Comparison between Nasal Vaccine and its injectable counterparts
Comparing nasal vaccinations to their injectable counterparts reveals significant advantages. Nasal vaccinations offer protection at the virus’ entry locations, the nose or upper respiratory tract, in addition to being simple to store, distribute, and produce less waste.
The Union Health Minister Mansukh Mandaviya’s call for vaccination and Covid-appropriate behaviour, including the use of masks in crowded locations, has brought immunisation into sharp spotlight.
The first intra-nasal COVID vaccination in the world was licenced for limited usage in emergency conditions in people aged 18 and over on December 1 by India’s Central Drugs Standard Shoppingmode Control Organization (CDSCO).
Both an inhalable vaccination and a nasal spray vaccine have received approval from China. Additionally, Iran and Russia have produced and used their own mucosal vaccines.
Also Read: India takes measures to avoid China like Covid surge on a War footing level: Key Developments
Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOK, INSTAGRAM, and TWITTER
